Published in Front Physiol on April 02, 2012
Pathophysiology of autoimmune pancreatitis. World J Gastrointest Pathophysiol (2014) 0.88
Recent advances in pancreatology. Front Physiol (2014) 0.75
Prevalence and Clinicopathological Features of Triaditis in a Prospective Case Series of Symptomatic and Asymptomatic Cats. J Vet Intern Med (2016) 0.75
High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med (2001) 12.49
Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med (2009) 4.48
Defining criteria for autoimmune diseases (Witebsky's postulates revisited) Immunol Today (1993) 3.81
Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett (2004) 3.43
Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol (2006) 3.40
Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology (2000) 2.88
Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci U S A (2004) 2.16
Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet (1998) 2.15
Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J Gastroenterol (2011) 2.05
HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology (2002) 1.92
TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol (2011) 1.88
Corticosteroids correct aberrant CFTR localization in the duct and regenerate acinar cells in autoimmune pancreatitis. Gastroenterology (2010) 1.86
Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Am J Gastroenterol (2008) 1.67
Recent advances in autoimmune pancreatitis. Gut (2009) 1.44
Lactoferrin: an important host defence against microbial and viral attack. Cell Mol Life Sci (2005) 1.39
Experimental immune-mediated pancreatitis in neonatally thymectomized mice immunized with carbonic anhydrase II and lactoferrin. Lab Invest (2002) 1.31
Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production. J Biol Chem (2004) 1.31
Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry? J Cell Mol Med (2005) 1.29
Recent concepts of autoimmune pancreatitis and IgG4-related disease. Clin Rev Allergy Immunol (2011) 1.21
Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis. Pancreas (2006) 1.20
Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients' sera. Histopathology (2005) 1.19
The critical role of Toll-like receptor signaling pathways in the induction and progression of autoimmune diseases. Curr Mol Med (2009) 1.19
Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis. J Gastroenterol (2008) 1.18
Spontaneous development of pancreatitis in the MRL/Mp strain of mice in autoimmune mechanism. Clin Exp Immunol (1992) 1.16
Autoimmune pancreatitis results from loss of TGFbeta signalling in S100A4-positive dendritic cells. Gut (2009) 1.16
Autoimmune pancreatitis and complement activation system. Pancreas (2006) 1.15
Spontaneous development of a pancreatic exocrine disease in CD28-deficient NOD mice. J Immunol (2008) 1.14
Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis. Gut (2005) 1.13
Involvement of activation of toll-like receptors and nucleotide-binding oligomerization domain-like receptors in enhanced IgG4 responses in autoimmune pancreatitis. Arthritis Rheum (2012) 1.07
Commensal flora and the regulation of inflammatory and autoimmune responses. Semin Immunol (2011) 1.06
Autoimmune pancreatitis in Japan: overview and perspective. J Gastroenterol (2009) 1.06
Possible involvement of T helper type 2 responses to Toll-like receptor ligands in IgG4-related sclerosing disease. Gut (2010) 1.05
Amylase alpha-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant type 1 diabetes. Diabetes (2008) 1.03
Induction of experimental autoimmune sialoadenitis by immunization of PL/J mice with carbonic anhydrase II. J Immunol (1995) 1.02
Two critical genes (HLA-DRB1 and ABCF1)in the HLA region are associated with the susceptibility to autoimmune pancreatitis. Immunogenetics (2006) 1.00
Autoimmune disease of exocrine organs in immunodeficient alymphoplasia mice: a spontaneous model for Sjögren's syndrome. Eur J Immunol (1996) 0.97
Homeostatic maintenance of pathogen-containing vacuoles requires TBK1-dependent regulation of aquaporin-1. Cell Microbiol (2008) 0.97
Autoimmune pancreatitis: frequency, IgG4 expression, and clonality of T and B cells. Am J Surg Pathol (2007) 0.96
A novel immunoglobulin-immunoglobulin interaction in autoimmunity. PLoS One (2008) 0.96
Roles of capsule and lipopolysaccharide O antigen in interactions of human monocyte-derived dendritic cells and Klebsiella pneumoniae. Infect Immun (2009) 0.95
Thymus transplantation, a critical factor for correction of autoimmune disease in aging MRL/+mice. Proc Natl Acad Sci U S A (1996) 0.95
A novel autoimmune pancreatitis model in MRL mice treated with polyinosinic:polycytidylic acid. Clin Exp Immunol (2002) 0.94
Lipooligosaccharide of Campylobacter jejuni: similarity with multiple types of mammalian glycans beyond gangliosides. J Biol Chem (2011) 0.92
A mouse model of autoimmune pancreatitis with salivary gland involvement triggered by innate immunity via persistent exposure to avirulent bacteria. Lab Invest (2010) 0.91
Human risk allele HLA-DRB1*0405 predisposes class II transgenic Ab0 NOD mice to autoimmune pancreatitis. Gastroenterology (2010) 0.89
Pro-resolution immunological networks: binding immunoglobulin protein and other resolution-associated molecular patterns. Rheumatology (Oxford) (2011) 0.89
Long-term bacterial exposure can trigger nonsuppurative destructive cholangitis associated with multifocal epithelial inflammation. Lab Invest (2010) 0.88
An experimental model of autoimmune pancreatitis in the rat. Am J Pathol (2005) 0.88
Different susceptibility of mice to immune-mediated cholangitis induced by immunization with carbonic anhydrase II. Lab Invest (1998) 0.88
Deposition of complement C3c, immunoglobulin (Ig)G4 and IgG at the basement membrane of pancreatic ducts and acini in autoimmune pancreatitis. Histopathology (2010) 0.86
Exocrinopathy resembling Sjögren's syndrome induced by a murine retrovirus. Lab Invest (1993) 0.86
HSP 10 is a new autoantigen in both autoimmune pancreatitis and fulminant type 1 diabetes. Biochem Biophys Res Commun (2009) 0.86
Carbonic anhydrase in human pancreas: hypotheses for the pathophysiological roles of CA isozymes. Ann N Y Acad Sci (1999) 0.86
T cell-mediated exocrine pancreatic damage in major histocompatibility complex class II-deficient mice. Gastroenterology (1998) 0.85
The role of innate immunity in the pathogenesis of experimental autoimmune pancreatitis in mice. Pancreas (2011) 0.85
Toll-like receptor 3 signaling induces chronic pancreatitis through the Fas/Fas ligand-mediated cytotoxicity. Tohoku J Exp Med (2009) 0.84
Analysis of humoral immune response in experimental autoimmune pancreatitis in mice. Pancreas (2010) 0.84
Microbial adjuvant and autoimmunity. IV. Production of lesions in the exocrine pancreas of mice by repeated injection of syngeneic pancreatic extract together with the capsular polysaccharide of Klebsiella pneumoniae. Microbiol Immunol (1980) 0.82
The Wistar Bonn Kobori rat, a unique animal model for autoimmune pancreatitis with extrapancreatic exocrinopathy. Clin Exp Immunol (2008) 0.82
Kinetic analysis of the development of pancreatic lesions in mice infected with a murine retrovirus. Clin Immunol (2003) 0.81
Sequential histopathology of pancreatic tissues in aly/aly mice. Cells Tissues Organs (2007) 0.80
Accumulation of aquaporin-1 during hemolysin-induced necrotic cell death. Cell Mol Biol Lett (2008) 0.80
Aquaporin 1 water channel is overexpressed in the plasma membranes of pancreatic ducts in patients with autoimmune pancreatitis. J Med Invest (2009) 0.78
A novel heterophilic antibody interaction involves IgG4. Scand J Immunol (2010) 0.78
Are dysregulated inflammatory responses to commensal bacteria involved in the pathogenesis of hepatobiliary-pancreatic autoimmune disease? An analysis using mice models of primary biliary cirrhosis and autoimmune pancreatitis. ISRN Gastroenterol (2011) 0.77
Effects of splenectomy on spontaneously chronic pancreatitis in aly/aly mice. Clin Dev Immunol (2010) 0.77
Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol (2006) 3.04
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52
Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis. J Hepatol (2007) 2.33
Japanese clinical guidelines for autoimmune pancreatitis. Pancreas (2009) 2.11
Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep (2011) 2.09
Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol (2007) 1.87
Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol (2009) 1.64
Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study. Cancer Immunol Immunother (2006) 1.59
Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. J Gastroenterol Hepatol (2008) 1.49
A murine model of acute liver injury induced by human monoclonal autoantibody. Hepatology (2005) 1.43
Effect of cholecystokinin1 receptor antagonist loxiglumide (CR1505) on basal pancreatic exocrine secretion in conscious rats. Pancreas (2003) 1.40
Prevalence of pancreatic and biliary tract tumors in pancreas divisum. J Gastroenterol (2006) 1.39
Biliary tract involvement in autoimmune pancreatitis. Pancreas (2005) 1.32
Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol (2014) 1.26
Complete genome sequencing and analysis of a Lancefield group G Streptococcus dysgalactiae subsp. equisimilis strain causing streptococcal toxic shock syndrome (STSS). BMC Genomics (2011) 1.19
Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma. Cancer Immunol Immunother (2011) 1.18
Involvement of the IL-22/REG Ialpha axis in ulcerative colitis. Lab Invest (2010) 1.13
The revised Japanese clinical diagnostic criteria for chronic pancreatitis. J Gastroenterol (2010) 1.12
Comprehensive expression profiles of genes for protein tyrosine phosphatases in immune cells. Sci Signal (2010) 1.09
Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH. J Gastroenterol (2004) 1.09
Prospective study of hepatocellular carcinoma in nonalcoholic steatohepatitis in comparison with hepatocellular carcinoma caused by chronic hepatitis C. J Gastroenterol (2010) 1.08
Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol (2006) 1.04
The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease. Hepatol Res (2005) 1.03
Immune evasion by Staphylococcus aureus conferred by iron-regulated surface determinant protein IsdH. Microbiology (2009) 1.02
Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med (2006) 1.00
Somatic mutations in PIK3CA and activation of AKT in intraductal tubulopapillary neoplasms of the pancreas. Am J Surg Pathol (2011) 1.00
Differentiation between autoimmune pancreatitis and pancreatic carcinoma based on endoscopic retrograde cholangiopancreatography findings. J Gastroenterol (2010) 0.99
Cytokines and peroxisome proliferator-activated receptor gamma ligand regulate phagocytosis by pancreatic stellate cells. Gastroenterology (2005) 0.99
A co-stimulatory molecule on activated T cells, H4/ICOS, delivers specific signals in T(h) cells and regulates their responses. Int Immunol (2002) 0.99
Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful? J Gastroenterol (2005) 0.98
Liver failure caused by non-alcoholic steatohepatitis in an obese young male. J Gastroenterol Hepatol (2005) 0.97
Pancreatic diabetes in a follow-up survey of chronic pancreatitis in Japan. J Gastroenterol (2007) 0.96
Identification of SMURF1 as a possible target for 7q21.3-22.1 amplification detected in a pancreatic cancer cell line by in-house array-based comparative genomic hybridization. Cancer Sci (2008) 0.96
Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease. J Gastroenterol (2009) 0.95
Influence of age and gender in Japanese patients with non-alcoholic steatohepatitis. Hepatol Res (2007) 0.93
Evolutionary paths of streptococcal and staphylococcal superantigens. BMC Genomics (2012) 0.93
High-sensitivity C-reactive protein as a serum predictor of nonalcoholic fatty liver disease based on the Akaike Information Criterion scoring system in the general Japanese population. J Gastroenterol (2009) 0.93
Expression and function of the co-stimulator H4/ICOS on activated T cells of patients with rheumatoid arthritis. J Rheumatol (2003) 0.92
Thiazolidinedione derivatives as novel therapeutic agents to prevent the development of chronic pancreatitis. Pancreas (2002) 0.92
Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol (2014) 0.92
A mouse model of autoimmune pancreatitis with salivary gland involvement triggered by innate immunity via persistent exposure to avirulent bacteria. Lab Invest (2010) 0.91
Association of epidermal growth factor receptor and mitogen-activated protein kinase with cystic neoplasms of the pancreas. Mod Pathol (2010) 0.91
Pigment-epithelium-derived factor (PEDF) inhibits angiotensin-II-induced vascular endothelial growth factor (VEGF) expression in MOLT-3 T cells through anti-oxidative properties. Microvasc Res (2006) 0.91
Akt is a neutral amplifier for Th cell differentiation. J Biol Chem (2004) 0.90
Imaging of nonalcoholic steatohepatitis: advantages and pitfalls of ultrasonography and computed tomography. Intern Med (2009) 0.89
Treatment of nonalcoholic steatohepatitis with colestimide. Hepatol Res (2009) 0.89
Continuous exposure of mice to superantigenic toxins induces a high-level protracted expansion and an immunological memory in the toxin-reactive CD4+ T cells. J Immunol (2002) 0.89
Long-term bacterial exposure can trigger nonsuppurative destructive cholangitis associated with multifocal epithelial inflammation. Lab Invest (2010) 0.88
Pediatric nonalcoholic steatohepatitis associated with hypopituitarism. J Gastroenterol (2005) 0.88
Comparison of hepatocellular carcinoma patients with alcoholic liver disease and nonalcoholic steatohepatitis. Alcohol Clin Exp Res (2004) 0.88
Hepatic and extrahepatic malignancies in cirrhosis caused by nonalcoholic steatohepatitis and alcoholic liver disease. Alcohol Clin Exp Res (2013) 0.86
Abnormalities of the small intestine detected by capsule endoscopy in hemodialysis patients. Intern Med (2012) 0.85
Serum metabolomic profile and potential biomarkers for severity of fibrosis in nonalcoholic fatty liver disease. J Gastroenterol (2013) 0.85
Staphylococcal enterotoxin B toxic shock syndrome induced by community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA). Intern Med (2012) 0.84
Familial aggregation in patients with non-alcoholic steatohepatitis. Intern Med (2008) 0.84
Involvement of aberrant DNA methylation on reduced expression of lysophosphatidic acid receptor-1 gene in rat tumor cell lines. Biochem Biophys Res Commun (2006) 0.84
Troglitazone inhibits the progression of chronic pancreatitis and the profibrogenic activity of pancreatic stellate cells via a PPARgamma-independent mechanism. Pancreas (2004) 0.84
Clinical profile of primary biliary cirrhosis with features of autoimmune hepatitis: Importance of corticosteroid therapy. Hepatol Res (2013) 0.84
Influence of TNF gene polymorphism in patients with acute and fulminant hepatitis. J Gastroenterol (2004) 0.83
Molecular characteristics and biological behaviours of the oncocytic and pancreatobiliary subtypes of intraductal papillary mucinous neoplasms. J Pathol (2011) 0.83
Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas. Pancreas (2015) 0.83
Shrinking and development of lipid droplets in adipocytes during catecholamine-induced lipolysis. FEBS Lett (2010) 0.82
Efficacy of oral administered superfine dispersed lentinan for advanced pancreatic cancer. Hepatogastroenterology (2009) 0.82
Clinicopathologic features of patients with primary malignant hepatic tumors seropositive for alpha-fetoprotein-L3 alone in comparison with other patients seropositive for alpha-fetoprotein-L3. J Gastroenterol Hepatol (2005) 0.82
Plasma leukocyte cell-derived chemotaxin 2 is associated with the severity of systemic inflammation in patients with sepsis. Microbiol Immunol (2012) 0.82
Possible involvement of cytokine gene polymorphisms in fulminant hepatitis. J Gastroenterol Hepatol (2007) 0.82
ICOS gene haplotypes correlate with IL10 secretion and multiple sclerosis evolution. J Neuroimmunol (2007) 0.82
Immunologic immaturity, but high IL-4 productivity, of murine neonatal thymic CD4 single-positive T cells in the last stage of maturation. Int Immunol (2004) 0.82
Long-term follow up of esophageal varices after balloon-occluded retrograde transvenous obliteration for gastric varices. Hepatol Res (2007) 0.82
Aberrant DNA methylation of E-cadherin and p16 genes in rat lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine. Mol Carcinog (2006) 0.82
Intrahepatic biliary epithelial cell damage and inflammation in portal tract in association with chronic colitis-harboring TCRalpha(-/-) mice. Hepatol Res (2005) 0.81
Targeting of MAPK-associated molecules identifies SON as a prime target to attenuate the proliferation and tumorigenicity of pancreatic cancer cells. Mol Cancer (2012) 0.81
Possible involvement of T cell co-stimulation in pustulosis palmaris et plantaris via the induction of inducible co-stimulator in chronic focal infections. J Dermatol Sci (2008) 0.81
Engulfment of necrotic acinar cells by pancreatic stellate cells inhibits pancreatic fibrogenesis. Pancreas (2008) 0.81
Expression and DNA methylation patterns of Tslc1 and Dal-1 genes in hepatocellular carcinomas induced by N-nitrosodiethylamine in rats. Cancer Sci (2007) 0.81
Long-term exposure to superantigen induces p27Kip1 and Bcl-2 expression in effector memory CD4+ T cells. Cell Immunol (2007) 0.81
Lipoteichoic acid may affect the pathogenesis of PBC-like bile duct damage and might be involved in systemic multifocal epithelial inflammations in chronic colitis-harboring TCRalpha-/-xAIM-/- mice. Autoimmunity (2007) 0.80
Clinical and pathological features of solid pseudopapillary neoplasms of the pancreas at a single institution. Dig Surg (2014) 0.80
Optimal temperature range for low-temperature preservation of dissociated neonatal rat cardiomyocytes. Cryobiology (2011) 0.80
B7h triggering inhibits umbilical vascular endothelial cell adhesiveness to tumor cell lines and polymorphonuclear cells. J Immunol (2010) 0.80
Lipoteichoic acid may affect the pathogenesis of bile duct damage in primary biliary cirrhosis. Autoimmunity (2006) 0.80
ICOS cooperates with CD28, IL-2, and IFN-gamma and modulates activation of human naïve CD4+ T cells. Eur J Immunol (2006) 0.80
Impact of the Timing of Morphine Administration on Lipopolysaccharide-Mediated Lethal Endotoxic Shock in Mice. Shock (2016) 0.80
Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol (2006) 0.79
Cloning of the hamster p16 gene 5' upstream region and its aberrant methylation patterns in pancreatic cancer. Biochem Biophys Res Commun (2005) 0.79
Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 II. Extrapancreatic lesions, differential diagnosis. J Gastroenterol (2014) 0.79
Reduced T cell expansion by a superantigen as a result of impaired B cell development in mice deficient for the p85alpha regulatory subunit of PI3K. J Leukoc Biol (2009) 0.79
Differential induction of IL-17, IL-10, and IL-9 in human T helper cells by B7h and B7.1. Cytokine (2013) 0.79
Clinical Practice Guidelines for Pancreatic Cancer 2016 From the Japan Pancreas Society: A Synopsis. Pancreas (2017) 0.79